Laevolac 666.7 mg/ml and 10 g/15 ml lactulose, and Laevolac Plum 666.7 mg/ml and 10 g/15 ml lactulose, are non-prescription medicines. Laevolac and Laevolac Plum are indicated for the treatment of chronic constipation (in all cases) and hepatic/portosystemic encephalopathy. Contraindications: hypersensitivity to lactulose or to any of the excipients, galactosemia, lactose intolerance, galactose-free diet, intestinal obstruction or suspected paralytic ileus. Special warnings and precautions for use: The usual dose should not present a problem for diabetic patients, as the sugars contained in the syrup do not increase blood glucose levels. If diarrhoea occurs, the dose should be reduced; if this measure is not effective, the medicine should be discontinued. This product contains galactose and tagatose. If you are diabetic, you should take this into account. If you have been told that you are intolerant to certain sugars, consult your doctor before taking this medicine. Date of revision of the text: 09/2024 Marketing Authorisation Holder: FERRAZ, LYNCE, ESPECIALIDADES FARMACÊUTICAS, S.A. Estrada Consiglieri Pedroso, nº 123 – Queluz de Baixo 2734-501 BARCARENA, TIN 500113270. Read the information on the packaging and in the package leaflet carefully. In case of doubt or if symptoms persist, consult your doctor or pharmacist.